This brand name is authorized in Japan, South Africa
The drug MIKELAN contains one active pharmaceutical ingredient (API):
|
1
Carteolol
UNII 4797W6I0T4 - CARTEOLOL HYDROCHLORIDE
|
|
Carteolol is a non-selective beta-adrenergic blocking agent with associated intrinsic sympathomimetic activity (ISA) and without significant membrane stabilizing activity. Carteolol reduces normal and elevated intraocular pressure whether or not accompanied by glaucoma. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C07AA15 | Carteolol | C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AA Beta blocking agents, non-selective |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 1319701Q1021, 1319701Q2028, 1319701Q3024, 1319701Q4020, 2123005C1030, 2123005C2036, 2123005F1141, 2149025N1034 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): N/5.2/95 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
